451 | 18645412 | In vivo cerebrovascular effects of cocaine- and amphetamine-regulated transcript (CART) peptide. | J Cardiovasc Pharmacol | 2008 Jul |
1 |
452 | 18758506 | Effect of the putative novel selective ETA-receptor antagonist HJP272, a 1,3,6-trisubstituted-2-carboxy-quinol-4-one, on infection-mediated premature delivery. | Can J Physiol Pharmacol | 2008 Aug |
1 |
453 | 18772340 | The endothelin-converting enzyme-1/endothelin-1 pathway plays a critical role in inflammation-associated premature delivery in a mouse model. | Am J Pathol | 2008 Oct |
1 |
454 | 18804491 | Role of the rat gastrointestinal mucosa in catabolism of endothelin peptides. | Regul Pept | 2008 Nov 29 |
1 |
455 | 18992253 | Structure of human endothelin-converting enzyme I complexed with phosphoramidon. | J Mol Biol | 2009 Jan 9 |
1 |
456 | 19151386 | Functional and molecular characterization of the endothelin system in retinal arterioles. | Invest Ophthalmol Vis Sci | 2009 Jul |
3 |
457 | 19520130 | Intrathecal substance P augments morphine-induced antinociception: possible relevance in the production of substance P N-terminal fragments. | Peptides | 2009 Sep |
1 |
458 | 19780404 | Neutral endopeptidase inhibition enhances substance P mediated inflammation due to hypomagnesemia. | Magnes Res | 2009 Sep |
1 |
459 | 19962413 | Diabetes-associated changes and role of N epsilon-(carboxymethyl)lysine in big ET-1-induced coronary vasoconstriction. | Peptides | 2010 Feb |
1 |
460 | 20088804 | NEP-like endopeptidases and Alzheimer's disease [corrected]. | Curr Alzheimer Res | 2010 May |
3 |
461 | 20504728 | Phosphoramidon potentiates the endothelin-1-induced bronchopulmonary response in guinea-pigs. | Neurochem Int | 1991 |
5 |
462 | 20522806 | Increased endothelial exocytosis and generation of endothelin-1 contributes to constriction of aged arteries. | Circ Res | 2010 Jul 23 |
1 |
463 | 20796280 | Autocrine regulation of human sperm motility by tachykinins. | Reprod Biol Endocrinol | 2010 Aug 26 |
3 |
464 | 20941644 | Intranasal phosphoramidon increases beta-amyloid levels in wild-type and NEP/NEP2-deficient mice. | J Mol Neurosci | 2011 Mar |
13 |
465 | 21174590 | Endothelin-1 expression by vascular endothelial growth factor in human umbilical vein endothelial cells and aortic smooth muscle cells. | Hypertens Pregnancy | 2011 |
3 |
466 | 21224067 | Neprilysin-2 is an important β-amyloid degrading enzyme. | Am J Pathol | 2011 Jan |
10 |
467 | 21459096 | Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation. | J Mol Cell Cardiol | 2011 Jul |
3 |
468 | 21651905 | Endothelial angiotensin-converting enzyme and neutral endopeptidase in isolated human umbilical vein: an effective bradykinin inactivation pathway. | Eur J Pharmacol | 2011 Sep 30 |
2 |
469 | 21937235 | Structure-based design of dipeptide derivatives for the human neutral endopeptidase. | Bioorg Med Chem | 2011 Oct 15 |
2 |
470 | 22387410 | Context-dependent toxicity of amyloid-β peptides on mouse cerebellar cells. | J Alzheimers Dis | 2012 |
1 |
471 | 22554773 | Neurogenic airway microvascular leakage induced by toluene inhalation in rats. | Eur J Pharmacol | 2012 Jun 15 |
1 |
472 | 22642296 | A smallest 6 kda metalloprotease, mini-matrilysin, in living world: a revolutionary conserved zinc-dependent proteolytic domain- helix-loop-helix catalytic zinc binding domain (ZBD). | J Biomed Sci | 2012 May 29 |
1 |
473 | 23113990 | Dynamic changes in the secondary structure of ECE-1 and XCE account for their different substrate specificities. | BMC Bioinformatics | 2012 Nov 1 |
2 |
474 | 23528219 | Inhibition of neuropeptide degradation suppresses sweating but increases the area of the axon reflex flare. | Exp Dermatol | 2013 Apr |
4 |
475 | 23868737 | Increase in antinociceptive effect of [leu5]enkephalin after intrathecal administration of mixture of three peptidase inhibitors. | Tokai J Exp Clin Med | 2013 Jul 20 |
1 |
476 | 23911580 | Regulation of endothelin-converting enzyme-1 (ECE-1) by the calcimimetic R-568. | Pharmacol Res | 2013 Oct |
2 |
477 | 23963369 | Contributions of degradation and brain-to-blood elimination across the blood-brain barrier to cerebral clearance of human amyloid-β peptide(1-40) in mouse brain. | J Cereb Blood Flow Metab | 2013 Nov |
2 |
478 | 24000822 | Exploring mode of phosphoramidon and Aβ peptide binding to hECE-1 by molecular dynamics and docking studies. | Protein Pept Lett | 2014 |
3 |
479 | 24069438 | Disruption of the endothelial barrier by proteases from the bacterial pathogen Pseudomonas aeruginosa: implication of matrilysis and receptor cleavage. | PLoS One | 2013 |
3 |
480 | 24287321 | "To serve and protect": enzyme inhibitors as radiopeptide escorts promote tumor targeting. | J Nucl Med | 2014 Jan |
2 |
481 | 25165447 | Amyloid-beta and Alzheimer's disease: the role of neprilysin-2 in amyloid-beta clearance. | Front Aging Neurosci | 2014 |
4 |
482 | 25286347 | In vivo enzyme inhibition improves the targeting of [177Lu]DOTA-GRP(13-27) in GRPR-positive tumors in mice. | Cancer Biother Radiopharm | 2014 Nov |
5 |
483 | 25457559 | γ-Hydroxybutyrate (Xyrem) ameliorates clinical symptoms and neuropathology in a mouse model of Alzheimer's disease. | Neurobiol Aging | 2015 Feb |
2 |
484 | 25488751 | In vivo radioimaging of bradykinin receptor b1, a widely overexpressed molecule in human cancer. | Cancer Res | 2015 Jan 15 |
1 |
485 | 25836673 | A chicken model of pharmacologically-induced Hirschsprung disease reveals an unexpected role of glucocorticoids in enteric aganglionosis. | Biol Open | 2015 Apr 2 |
1 |
486 | 26158215 | Radiolabeled gastrin/CCK analogs in tumor diagnosis: towards higher stability and improved tumor targeting. | Q J Nucl Med Mol Imaging | 2015 Sep |
5 |
487 | 26300210 | In vivo inhibition of neutral endopeptidase enhances the diagnostic potential of truncated gastrin (111)In-radioligands. | Nucl Med Biol | 2015 Nov |
1 |
488 | 26722377 | In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies. | Theranostics | 2016 |
5 |
489 | 26844849 | Improving the In Vivo Profile of Minigastrin Radiotracers: A Comparative Study Involving the Neutral Endopeptidase Inhibitor Phosphoramidon. | Cancer Biother Radiopharm | 2016 Feb |
2 |
490 | 26881775 | CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor Prognosis. | PLoS One | 2016 |
3 |
491 | 26882895 | Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11-first estimates for clinical translation. | EJNMMI Res | 2016 Dec |
4 |
492 | 26996808 | New KEL*01M and KEL*02M alleles: structural modeling to assess the impact of amino acid changes. | Transfusion | 2016 May |
1 |
493 | 27062279 | Immature endothelial cells initiate endothelin-mediated constriction of newborn arteries. | J Physiol | 2016 Sep 1 |
1 |
494 | 27840228 | Region-specific bioconversion of dynorphin neuropeptide detected by in situ histochemistry and MALDI imaging mass spectrometry. | Peptides | 2017 Jan |
2 |
495 | 28636973 | Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors. | Nucl Med Biol | 2017 Sep |
4 |
496 | 29556947 | In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer. | Mol Imaging Biol | 2018 Dec |
5 |
497 | 29664606 | Radiometal-Dependent Biological Profile of the Radiolabeled Gastrin-Releasing Peptide Receptor Antagonist SB3 in Cancer Theranostics: Metabolic and Biodistribution Patterns Defined by Neprilysin. | Bioconjug Chem | 2018 May 16 |
2 |
498 | 30002107 | Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog <sup>177</sup>Lu-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution? | J Nucl Med | 2019 Mar |
1 |
499 | 30082509 | Phosphoramidon inhibits the integral membrane protein zinc metalloprotease ZMPSTE24. | Acta Crystallogr D Struct Biol | 2018 Aug 1 |
4 |
500 | 30537985 | 5-HIAA induces neprilysin to ameliorate pathophysiology and symptoms in a mouse model for Alzheimer's disease. | Acta Neuropathol Commun | 2018 Dec 11 |
1 |